Guggenheim Capital’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Sell
21,755
-41,344
-66% -$1.11M ﹤0.01% 1127
2026
Q1
$1.31M Buy
63,099
+41,689
+195% +$985K 0.01% 875
2025
Q4
$695K Sell
21,410
-4,137
-16% -$177K 0.01% 1127
2025
Q3
$1.45M Buy
25,547
+321
+1% +$16.4K 0.01% 793
2025
Q2
$1.26M Sell
25,226
-2,935
-10% -$133K 0.01% 804
2025
Q1
$832K Buy
28,161
+16,829
+149% +$625K 0.01% 957
2024
Q4
$274K Buy
+11,332
New +$281K ﹤0.01% 1481

Other funds holding HIMS

Guggenheim Capital's HIMS Position: Q2 2026 in Review

Guggenheim Capital reduced its Hims & Hers Health (HIMS) stake by 66% in Q2 2026, selling an estimated $1.11M and leaving 21,755 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Guggenheim Capital first reported a position in HIMS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.45M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Guggenheim Capital held 21,755 shares of Hims & Hers Health worth $754K as of Q2 2026.
  • Guggenheim Capital sold 41,344 Hims & Hers Health shares in Q2 2026, an estimated $1.11M.
  • Hims & Hers Health made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1127 holding.
  • Guggenheim Capital first reported a position in Hims & Hers Health in Q4 2024 and has held it in 7 quarters since.
  • Guggenheim Capital's Hims & Hers Health position peaked at $1.45M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.